Cytokeratins - Clinical utility in breast cancer

被引：0

作者：

Barak, V ^{[1
]}

Nisman, B ^{[1
]}

Hubert, A ^{[1
]}

Lyass, O ^{[1
]}

Peretz, T ^{[1
]}

机构：

[1] Hadassah Univ Hosp, Dept Oncol, Immunol Lab Tumor Diagnosis, IL-12000 Jerusalem, Israel

来源：

JOURNAL OF CLINICAL LIGAND ASSAY | 2002年 / 25卷 / 01期

关键词：

cytokeratins; TPS; breast cancer; prognosis; monitoring;

D O I：

暂无

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Cytokeratins belong to the intermediate filament protein family which is a component of the cytoskeleton of epithelial cells. The most abundant cytokeratins present in epithelial tumors are cytokeratins 8,18, and 19. TPA, TPS, and CYFRA 21-1, based on fragments of these cytokeratins, are the three cytokeratin markers in clinical use today. They are mainly used for treatment monitoring in cancer patients, but also for diagnosis (in lung carcinoma) and for prognosis in several types of cancers, especially in breast cancer.

引用

页码：40 / 42

页数：3

共 50 条

[41] Commentary: Polygenic risk for breast cancer: in search for potential clinical utility
Wang, Tingting
Ala-Korpela, Mika
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 (06) : 1911 - 1913
[42] Clinical utility of multi-gene testing in metastatic breast cancer
Bedard, P.
CANCER RESEARCH, 2017, 77
[43] Genetic profiling of breast cancer: From molecular portraits to clinical utility
Borresen-Dale, AL
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (01): : 54 - 56
[44] Clinical Utility and Therapeutic Implications of Oncotype Analysis in Patients With Breast Cancer
Tatarian, Talar
Damle, Sameer
McSwain, Anita P.
Ojong-Ntui, Martin
Tabbara, Imad
Teal, Christine B.
ANNALS OF SURGICAL ONCOLOGY, 2011, 18 : S182 - S182
[45] Utility of Circulating Tumor DNA in Different Clinical Scenarios of Breast Cancer
Mesquita, Alexandra
Costa, Jose Luis
Schmitt, Fernando
CANCERS, 2020, 12 (12) : 1 - 14
[46] Clinical utility and therapeutic implications of oncotype analysis in patients with breast cancer
Williams, Stephanie A.
Tatarian, Talar
Teal, Christine B.
McSwain, Anita P.
Siegel, Robert S.
Ojong-Ntui, Martin
Saini, Ashima
Tabbara, Imad A.
Kaltman, Rebecca Davidson
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[47] Clinical Utility of Circulating Tumor Cells in Metastatic Breast Cancer Reply
Smerage, Jeffrey B.
Barlow, William E.
Hortobagyi, Gabriel N.
Hayes, Daniel F.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (14)
[48] Clinical utility of universal germline genetic testing for patients with breast cancer
Whitworth, Pat
Beitsch, Peter
Hardwick, Mary Kay
Wernecke, Chloe
Grady, Ian
Barbosa, Karen
Patel, Rakesh
Kinney, Michael
Baron, Paul
Rosen, Barry
Compagnoni, Gia
Smith, Linda
Simmons, Rache
Coomer, Cynara
Holmes, Dennis
Brown, Eric
Gold, Linsey
Curcio, Lisa
Clark, Patricia
Ruiz, Antonio
MacDonald, Heather
Khan, Sadia
Riley, Lee
Lyons, Samuel
Hughes, Kevin
Nussbaum, Robert
Munro, Sandra
Nielsen, Sarah
Esplin, Edward
ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 137 - 138
[49] Clinical utility of molecular imaging in newly diagnosed metastatic breast cancer
Schroder, Carolina Pia
van Geel, Jasper
Eisses, Bertha
Elias, Sjoerd G.
Brouwers, Adrienne H.
Bensch, Frederike
Gerritse, Sophie
Angus, Lindsay
Glaudemans, Andor W. J. M.
Kuip, Evelien J. M.
Jager, Agnes
Oprea-Lager, Daniela E.
Vugts, Danielle J.
Emmering, Jasper
Arens, Anne I. J.
Oyen, Wim J. G.
van der Vegt, Bert
Lub-de Hooge, Marjolijn N.
Menke, Catharina Wilhelmina
De Vries, Elisabeth
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[50] Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancer
Chlebowski, Rowan
Cuzick, Jack
Amakye, Dereck
Bauerfeind, Ingo
Buzdar, Aman
Chia, Stephen
Cutuli, Bruno
Linforth, Rick
Maass, Nicolai
Noguchi, Shinzaburo
Robidoux, Andre
Verma, Sunil
Hadji, Peyman
BREAST, 2009, 18 : S1 - S11

← 1 2 3 4 5 →